{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:52:33Z","timestamp":1761918753770},"reference-count":52,"publisher":"Informa UK Limited","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Scandinavian Journal of Gastroenterology"],"published-print":{"date-parts":[[2005,10,1]]},"DOI":"10.1080\/00365520510023369","type":"journal-article","created":{"date-parts":[[2005,9,19]],"date-time":"2005-09-19T18:13:33Z","timestamp":1127153613000},"page":"1205-1213","source":"Crossref","is-referenced-by-count":21,"title":["A prospective, open-label trial of 6-thioguanine in patients with ulcerative or indeterminate colitis"],"prefix":"10.1080","volume":"40","author":[{"given":"Alexander","family":"Teml","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marieluise","family":"Harrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Miehsler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elke","family":"Schaeffeler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Dejaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Mantl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Vogelsang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Reinisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"E00001","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1056\/NEJM199109263251306","volume":"325","author":"Podolsky DK","year":"1991","unstructured":"Podolsky, DK. (1991) Inflammatory bowel disease. I <i>N Engl J Med<\/i>, 325, pp. 928 - 37.","journal-title":"N Engl J Med"},{"key":"E00002","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1056\/NEJM199110033251406","volume":"325","author":"Podolsky DK","year":"1991","unstructured":"Podolsky, DK. (1991) Inflammatory bowel disease. II <i>N Engl J Med<\/i>, 325, pp. 1008 - 16.","journal-title":"N Engl J Med"},{"key":"E00003","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1136\/jcp.31.6.567","volume":"31","author":"Price AB","year":"1978","unstructured":"Price, AB. (1978) Overlap in the spectrum of non-specific inflammatory bowel disease: \u201ccolitis indeterminate\u201d <i>J Clin Pathol<\/i>, 31, pp. 567 - 77.","journal-title":"J Clin Pathol"},{"key":"E00004","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/00054725-200309000-00007","volume":"9","author":"Geboes K","year":"2003","unstructured":"Geboes, K and De Hertogh, G. (2003) Indeterminate colitis <i>Inflamm Bowel Dis<\/i>, 9, pp. 324 - 31.","journal-title":"Inflamm Bowel Dis"},{"key":"E00005","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1136\/bmj.4.5945.627","volume":"4","author":"Jewell DP","year":"1974","unstructured":"Jewell, DP and Truelove, SC. (1974) Azathioprine in ulcerative colitis: final report on controlled therapeutic trial <i>Br Med J<\/i>, 4, pp. 627 - 30.","journal-title":"Br Med J"},{"key":"E00006","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/S0016-5085(19)32641-1","volume":"69","author":"Rosenberg JL","year":"1975","unstructured":"Rosenberg, JL and Wall, AJ and Levin, B and Binder, HJ and Kirsner, JB. (1975) A controlled trial of azathioprine in the management of chronic ulcerative colitis <i>Gastroenterology<\/i>, 69, pp. 96 - 9.","journal-title":"Gastroenterology"},{"key":"E00007","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1136\/bmj.284.6325.1291","volume":"284","author":"Kirk AP","year":"1982","unstructured":"Kirk, AP and Lennard-Jones, JE. (1982) Controlled trial of azathioprine in chronic ulcerative colitis <i>Br Med J (Clin Res Ed)<\/i>, 284, pp. 1291 - 2.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"E00008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1136\/bmj.305.6844.20","volume":"305","author":"Hawthorne AB","year":"1992","unstructured":"Hawthorne, AB and Logan, RF and Hawkey, CJ and Foster, PN and Axon, AT and Swarbrick, ET and (1992) Randomised controlled trial of azathioprine withdrawal in ulcerative colitis <i>Br Med J<\/i>, 305, pp. 20 - 2.","journal-title":"Br Med J"},{"key":"E00009","first-page":"14","volume":"19","author":"Sood A","year":"2000","unstructured":"Sood, A and Midha, V and Sood, N and Kaushal, V. (2000) Role of azathioprine in severe ulcerative colitis: one-year, placebo-controlled, randomized trial <i>Indian J Gastroenterol<\/i>, 19, pp. 14 - 6.","journal-title":"Indian J Gastroenterol"},{"key":"E00010","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/gut.50.4.485","volume":"50","author":"Fraser AG","year":"2002","unstructured":"Fraser, AG and Orchard, TR and Jewell, DP. (2002) The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30-year review <i>Gut<\/i>, 50, pp. 485 - 9.","journal-title":"Gut"},{"key":"E00011","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJM198005013021801","volume":"302","author":"Present DH","year":"1980","unstructured":"Present, DH and Korelitz, BI and Wisch, N and Glass, JL and Sachar, DB and Pasternack, BS. (1980) Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double-blind study <i>N Engl J Med<\/i>, 302, pp. 981 - 7.","journal-title":"N Engl J Med"},{"key":"E00012","first-page":"83","volume":"47","author":"Ludwig D","year":"2000","unstructured":"Ludwig, D and Stange, EF. (2000) Treatment of ulcerative colitis <i>Hepatogastroenterology<\/i>, 47, pp. 83 - 9.","journal-title":"Hepatogastroenterology"},{"key":"E00013","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/BF02220605","volume":"43","author":"Lennard L","year":"1992","unstructured":"Lennard, L. (1992) The clinical pharmacology of 6-mercaptopurine <i>Eur J Clin Pharmacol<\/i>, 43, pp. 329 - 39.","journal-title":"Eur J Clin Pharmacol"},{"key":"E00014","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","volume":"122","author":"Dubinsky MC","year":"2002","unstructured":"Dubinsky, MC and Yang, H and Hassard, PV and Seidman, EG and Kam, LY and Abreu, MT and (2002) 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease <i>Gastroenterology<\/i>, 122, pp. 904 - 15.","journal-title":"Gastroenterology"},{"key":"E00015","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1046\/j.1365-2141.1998.00812.x","volume":"102","author":"Lancaster DL","year":"1998","unstructured":"Lancaster, DL and Lennard, L and Rowland, K and Vora, AJ and Lilleyman, JS. (1998) Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations <i>Br J Haematol<\/i>, 102, pp. 439 - 43.","journal-title":"Br J Haematol"},{"key":"E00016","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s002800050816","volume":"42","author":"Erb N","year":"1998","unstructured":"Erb, N and Harms, DO and Janka-Schaub, G. (1998) Pharmacokinetics and metabolism of thiopurines in children with acute lymphoblastic leukemia receiving 6-thioguanine versus 6-mercaptopurine <i>Cancer Chemother Pharmacol<\/i>, 42, pp. 266 - 72.","journal-title":"Cancer Chemother Pharmacol"},{"key":"E00017","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2141.1991.tb04520.x","volume":"79","author":"Shepherd PC","year":"1991","unstructured":"Shepherd, PC and Fooks, J and Gray, R and Allan, NC. (1991) Thioguanine used in maintenance therapy of chronic myeloid leukaemia causes non-cirrhotic portal hypertension. Results from MRC CML. II. Trial comparing busulphan with busulphan and thioguanine <i>Br J Haematol<\/i>, 79, pp. 185 - 92.","journal-title":"Br J Haematol"},{"key":"E00018","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1182\/blood-2002-08-2372","volume":"102","author":"Harms DO","year":"2003","unstructured":"Harms, DO and Gobel, U and Spaar, HJ and Graubner, UB and Jorch, N and Gutjahr, P and (2003) COALL Study Group. Thioguanine offers no advantage over mercaptopurine in maintenance treatment of childhood ALL: results of the randomized trial COALL-92 <i>Blood<\/i>, 102, pp. 2736 - 40.","journal-title":"Blood"},{"key":"E00019","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/bjc.1993.311","volume":"68","author":"Lennard L","year":"1993","unstructured":"Lennard, L and Davies, HA and Lilleyman, JS. (1993) Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia? <i>Br J Cancer<\/i>, 68, pp. 186 - 90.","journal-title":"Br J Cancer"},{"key":"E00020","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1067\/mjd.2001.109296","volume":"44","author":"Mason C","year":"2001","unstructured":"Mason, C and Krueger, GG. (2001) Thioguanine for refractory psoriasis: a 4-year experience <i>J Am Acad Dermatol<\/i>, 44, pp. 67 - 72.","journal-title":"J Am Acad Dermatol"},{"key":"E00021","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.1.5495.1081","volume":"1","author":"Bean RHD","year":"1966","unstructured":"Bean, RHD. (1966) Treatment of ulcerative colitis with antimetabolites <i>Br Med J<\/i>, 1, pp. 1081 - 4.","journal-title":"Br Med J"},{"key":"E00022","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00054725-200108000-00001","volume":"7","author":"Dubinsky MC","year":"2001","unstructured":"Dubinsky, MC and Hassard, PV and Seidman, EG and Kam, LY and Abreu, MT and Targan, SR and (2001) An open-label pilot study using thioguanine as a therapeutic alternative in Crohn's disease patients resistant to 6-mercaptopurine therapy <i>Inflamm Bowel Dis<\/i>, 7, pp. 181 - 9.","journal-title":"Inflamm Bowel Dis"},{"key":"E00023","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1365-2036.2003.01440.x","volume":"17","author":"Herrlinger KR","year":"2003","unstructured":"Herrlinger, KR and Kreisel, W and Schwab, M and Schoelmerich, J and Fleig, WE and Ruhl, A and (2003) 6-thioguanine: efficacy and safety in chronic active Crohn's disease <i>Aliment Pharmacol Ther<\/i>, 17, pp. 503 - 8.","journal-title":"Aliment Pharmacol Ther"},{"key":"E00024","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1365-2036.2003.01590.x","volume":"17","author":"Herrlinger KR","year":"2003","unstructured":"Herrlinger, KR and Deibert, P and Schwab, M and Kreisel, W and Fischer, C and Fellermann, K and (2003) Remission maintenance by thioguanine in chronic active Crohn's disease <i>Aliment Pharmacol Ther<\/i>, 17, pp. 1459 - 64.","journal-title":"Aliment Pharmacol Ther"},{"key":"E00025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1046\/j.1365-2036.2003.01683.x","volume":"18","author":"Bonaz B","year":"2003","unstructured":"Bonaz, B and Boitard, J and Marteau, P and Lemann, M and Coffin, B and Flourie, B and (2003) Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine\/mercaptopurine <i>Aliment Pharmacol Ther<\/i>, 18, pp. 401 - 8.","journal-title":"Aliment Pharmacol Ther"},{"key":"E00026","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00042737-200301000-00011","volume":"15","author":"Derijks LJ","year":"2003","unstructured":"Derijks, LJ and de Jong, DJ and Gilissen, LP and Engels, LG and Hooymans, PM and Jansen, JB and (2003) 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment <i>Eur J Gastroenterol Hepatol<\/i>, 15, pp. 63 - 7.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"E00027","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1572-0241.2003.07413.x","volume":"98","author":"Dubinsky MC","year":"2003","unstructured":"Dubinsky, MC and Feldman, EJ and Abreu, MT and Targan, SR and Vasiliauskas, EA. (2003) Thioguanine: a potential alternate thiopurine for IBD patients allergic to 6-mercaptopurine or azathioprine <i>Am J Gastroenterol<\/i>, 98, pp. 1058 - 63.","journal-title":"Am J Gastroenterol"},{"key":"E00028","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1046\/j.1445-5994.2003.00321.x","volume":"33","author":"Cheung TK","year":"2003","unstructured":"Cheung, TK and Florin, TH. (2003) 6-thioguanine: a new old drug to procure remission in inflammatory bowel disease <i>Intern Med J<\/i>, 33, pp. 44 - 6.","journal-title":"Intern Med J"},{"key":"E00029","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0016-5085(03)00938-7","volume":"125","author":"Dubinsky MC","year":"2003","unstructured":"Dubinsky, MC and Vasiliauskas, EA and Singh, H and Abreu, MT and Papadakis, KA and Tran, T and (2003) 6-thioguanine can cause serious liver injury in inflammatory bowel disease patients <i>Gastroenterology<\/i>, 125, pp. 298 - 303.","journal-title":"Gastroenterology"},{"key":"E00030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1053\/gast.2002.32980","volume":"122","author":"Joossens S","year":"2002","unstructured":"Joossens, S and Reinisch, W and Vermeire, S and Sendid, B and Poulain, D and Peeters, M and (2002) The value of serologic markers in indeterminate colitis: a prospective follow-up study <i>Gastroenterology<\/i>, 122, pp. 1242 - 7.","journal-title":"Gastroenterology"},{"key":"E00031","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1136\/bmj.298.6666.82","volume":"298","author":"Rachmilewitz D","year":"1989","unstructured":"Rachmilewitz, D. (1989) Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial <i>Br Med J<\/i>, 298, pp. 82 - 6.","journal-title":"Br Med J"},{"key":"E00032","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1056\/NEJM199406303302601","volume":"330","author":"Lichtiger S","year":"1994","unstructured":"Lichtiger, S and Present, DH and Kornbluth, A and Gelernt, I and Bauer, J and Galler, G and (1994) Cyclosporine in severe ulcerative colitis refractory to steroid therapy <i>N Engl J Med<\/i>, 330, pp. 1841 - 5.","journal-title":"N Engl J Med"},{"key":"E00033","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-2000-14868","volume":"38","author":"Rose M","year":"2000","unstructured":"Rose, M and Fliege, H and Hildebrandt, M and Korber, J and Arck, P and Dignass, A and (2000) Validierung der deutschsprachigen Version des \u201cShort Inflammatory Bowel Disease Questionnaire\u201d (SIBDQ) (Validation of the new German translation version of the \u201cShort Inflammatory Bowel Disease Questionnaire\u201d (SIBDQ)) <i>Z Gastroenterol<\/i>, 38, pp. 277 - 86.","journal-title":"Z Gastroenterol"},{"key":"E00034","first-page":"853","volume":"7","author":"Moser G","year":"1995","unstructured":"Moser, G and Tillinger, W and Sachs, G and Genser, D and Maier-Dobersberger, T and Spiess, K and (1995) Disease-related worries and concerns: a study on out-patients with inflammatory bowel disease <i>Eur J Gastroenterol Hepatol<\/i>, 7, pp. 853 - 8.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"E00035","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1093\/clinchem\/47.3.548","volume":"47","author":"Schaeffeler E","year":"2001","unstructured":"Schaeffeler, E and Lang, T and Zanger, UM and Eichelbaum, M and Schwab, M. (2001) High-throughput genotyping of thiopurine S-methyltransferase by denaturing HPLC <i>Clin Chem<\/i>, 47, pp. 548 - 55.","journal-title":"Clin Chem"},{"key":"E00036","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","volume":"14","author":"Schaeffeler E","year":"2004","unstructured":"Schaeffeler, E and Fischer, C and Brockmeier, D and Wernet, D and Moerike, K and Eichelbaum, M and (2004) Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants <i>Pharmacogenetics<\/i>, 14, pp. 407 - 17.","journal-title":"Pharmacogenetics"},{"key":"E00037","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1111\/j.1365-2036.2004.01947.x","volume":"19","author":"Herrlinger KR","year":"2004","unstructured":"Herrlinger, KR and Fellermann, K and Fischer, C and Kreisel, W and Deibert, P and Schoelmerich, J and (2004) Thioguanine-nucleotides do not predict efficacy of 6-tioguanine in Crohn's disease <i>Aliment Pharmacol Ther<\/i>, 19, pp. 1269 - 76.","journal-title":"Aliment Pharmacol Ther"},{"key":"E00038","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","volume":"47","author":"Miller AB","year":"1981","unstructured":"Miller, AB and Hoogstraten, B and Staquet, M and Winkler, A. (1981) Reporting results of cancer treatment <i>Cancer<\/i>, 47, pp. 207 - 14.","journal-title":"Cancer"},{"key":"E00039","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/gut.34.8.1081","volume":"34","author":"Connell WR","year":"1993","unstructured":"Connell, WR and Kamm, MA and Ritchie, JK and Lennard-Jones, JE. (1993) Bone marrow toxicity caused by azathioprine in inflammatory bowel disease: 27 years of experience <i>Gut<\/i>, 34, pp. 1081 - 5.","journal-title":"Gut"},{"key":"E00040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/0016-5085(89)90905-0","volume":"96","author":"Guyatt G","year":"1989","unstructured":"Guyatt, G and Michell, A and Irvine, EJ and Singer, J and Williams, N and Goodacre, R and Tompkins, C. (1989) A new measure of health status for clinical trials in inflammatory bowel disease <i>Gastroenterology<\/i>, 96, pp. 804 - 10.","journal-title":"Gastroenterology"},{"key":"E00041","first-page":"1571","volume":"91","author":"Irvine EJ","year":"1996","unstructured":"Irvine, EJ and Zhou, Q and Thompson, AK. (1996) The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT investigators. Canadian Crohn's Relapse Prevention Trial <i>Am J Gastroenterol<\/i>, 91, pp. 1571 - 8.","journal-title":"Am J Gastroenterol"},{"key":"E00042","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1007\/BF01538073","volume":"34","author":"Drossman DA","year":"1989","unstructured":"Drossman, DA and Patrick, DL and Mitchell, CM and Zagami, EA and Appelbaum, MI. (1989) Health-related quality of life in inflammatory bowel disease. Functional status and patient worries and concerns <i>Dig Dis Sci<\/i>, 34, pp. 1379 - 86.","journal-title":"Dig Dis Sci"},{"key":"E00043","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/00006842-199111000-00010","volume":"53","author":"Drossman DA","year":"1991","unstructured":"Drossman, DA and Leserman, J and Li, ZM and Mitchell, CM and Zagami, EA and Patrick, DL. (1991) The rating form of IBD patient concerns: a new measure of health status <i>Psychosom Med<\/i>, 53, pp. 701 - 12.","journal-title":"Psychosom Med"},{"key":"E00044","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1136\/gut.2003.032896","volume":"53","author":"Wright S","year":"2004","unstructured":"Wright, S and Sanders, DS and Lobo, AJ and Lennard, L. (2004) Clinical significance of azathioprine active metabolite concentrations in inflammatory bowel disease <i>Gut<\/i>, 53, pp. 1123 - 8.","journal-title":"Gut"},{"key":"E00045","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1053\/gast.2001.23983","volume":"120","author":"D'Haens G","year":"2001","unstructured":"D'Haens, G and Lemmens, L and Geboes, K and Vandeputte, L and Van Acker, F and Mortelmans, L and (2001) Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis <i>Gastroenterology<\/i>, 120, pp. 1323 - 9.","journal-title":"Gastroenterology"},{"key":"E00046","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0016-5085(99)70005-3","volume":"116","author":"D'Haens G","year":"1999","unstructured":"D'Haens, G and Van Deventer, S and Van Hogezand, R and Chalmers, D and Kothe, C and Baert, F and (1999) Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial <i>Gastroenterology<\/i>, 116, pp. 1029 - 34.","journal-title":"Gastroenterology"},{"key":"E00047","first-page":"930","volume":"113","author":"Kaser A","year":"2001","unstructured":"Kaser, A and Mairinger, T and Vogel, W and Tilg, H. (2001) Infliximab in severe steroid-refractory ulcerative colitis: a pilot study <i>Wien Klin Wochenschr<\/i>, 113, pp. 930 - 3.","journal-title":"Wien Klin Wochenschr"},{"key":"E00048","doi-asserted-by":"crossref","first-page":"49","DOI":"10.5858\/2004-128-49-ENHOTL","volume":"128","author":"Shastri S","year":"2004","unstructured":"Shastri, S and Dubinsky, MC and Poordad, FF and Vasiliauskas, EA and Geller, SA. (2004) Early nodular hyperplasia of the liver occurring with inflammatory bowel diseases in association with thioguanine therapy <i>Arch Pathol Lab Med<\/i>, 128, pp. 49 - 53.","journal-title":"Arch Pathol Lab Med"},{"key":"E00049","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/01.pas.0000128665.12063.97","volume":"28","author":"Geller SA","year":"2004","unstructured":"Geller, SA and Dubinsky, MC and Poordad, FF and Vasiliauskas, EA and Cohen, AH and Abreu, MT and (2004) Early hepatic nodular hyperplasia and submicroscopic fibrosis associated with 6-thioguanine therapy in inflammatory bowel disease <i>Am J Surg Pathol<\/i>, 28, pp. 1204 - 11.","journal-title":"Am J Surg Pathol"},{"key":"E00050","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1136\/gut.32.6.715","volume":"32","author":"Mion F","year":"1991","unstructured":"Mion, F and Napoleon, B and Berger, F and Chevallier, M and Bonvoisin, S and Descos, L. (1991) Azathioprine-induced liver disease: nodular regenerative hyperplasia of the liver and perivenous fibrosis in a patient treated for multiple sclerosis <i>Gut<\/i>, 32, pp. 715 - 7.","journal-title":"Gut"},{"key":"E00051","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1097\/00042737-200012050-00016","volume":"12","author":"Arnott ID","year":"2000","unstructured":"Arnott, ID and Ghosh, S. (2000) Portal hypertension in the presence of minimal liver damage in Crohn's disease on long-term azathioprine: possible endothelial cell injury <i>Eur J Gastroenterol Hepatol<\/i>, 12, pp. 569 - 73.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"E00052","first-page":"S1376","volume":"126","author":"Fady D","year":"2004","unstructured":"Fady, D and Cadranel, JF and Seksik, P and Cazier, A and Duong, JP and Ziol, M and (2004) Azathioprine-induced nodular regenerative hyperplasia (NRH) of the liver in IBD patients [abstract] <i>Gastroenterol<\/i>, 126, pp. S1376.","journal-title":"Gastroenterol"}],"container-title":["Scandinavian Journal of Gastroenterology"],"original-title":[],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T20:52:03Z","timestamp":1626555123000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/00365520510023369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,1]]},"references-count":52,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10,1]]}},"alternative-id":["QX014327034877TT"],"URL":"https:\/\/doi.org\/10.1080\/00365520510023369","relation":{},"ISSN":["0036-5521"],"issn-type":[{"value":"0036-5521","type":"print"}],"subject":[],"published":{"date-parts":[[2005,10,1]]}}}